Literature DB >> 14633092

Interstitial pneumonitis induced by bicalutamide and leuprorelin acetate for prostate cancer.

Koichi Shioi1, Minoru Yoshida, Naoki Sakai.   

Abstract

Maximal androgen blockade therapy is the standard endocrine treatment for advanced prostate cancer. We report here an unusual case of interstitial pneumonitis induced by bicalutamide and/or leuprorelin acetate treatment for metastatic prostate cancer.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14633092     DOI： 10.1046/j.1442-2042.2003.00705.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN： 0919-8172            Impact factor:   3.369


  3 in total

1.  Interstitial pneumonitis secondary to leuprorelin acetate for prostate cancer.

Authors:  Hsern Ern Tan; Fiona Lake
Journal:  Respirol Case Rep       Date:  2016-03-31

2.  Interstitial lung disease induced by apalutamide therapy for castration-resistant prostate cancer: A report of a rare case.

Authors:  Fumiaki Kirishima; Yoshinori Shigematsu; Kanao Kobayashi
Journal:  IJU Case Rep       Date:  2022-03-03

3.  Diffuse Leukoplakia of the Bladder Ostium-Sparing in Patient Treated with Leuprorelin for Breast Cancer.

Authors:  Antonio Nacchia; Ferdinando di Giacomo; Arcangelo Di Cerbo; Massimo Dante Di Somma; Giuseppe Patitucci; Giuseppe Disabato; Giulia Vita
Journal:  Case Rep Urol       Date:  2021-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.